Tata Health (01255.HK) receives additional resumption guidance from the Hong Kong Stock Exchange and will continue to be suspended from trading.

Wisdom Financial APP news, TATA Health (01255.HK) announced that on June 20, 2025, the company received a letter from the Hong Kong Stock Exchange, which listed additional guidelines for the resumption of trading of the company's shares on the Hong Kong Stock Exchange: to comply with listing rules 3.10(1) and 3.21. The company's shares continue to be suspended from trading.